BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 1933285)

  • 21. Release of immunoreactive Met-enkephalin from the spinal cord by intraventricular beta-endorphin but not morphine in anesthetized rats.
    Tseng LF; Higgins MJ; Hong JS; Hudson PM; Fujimoto JM
    Brain Res; 1985 Sep; 343(1):60-9. PubMed ID: 2864105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Down-regulation of N-methyl-D-aspartate (NMDA) receptors of brain regions and spinal cord of rats treated chronically with morphine.
    Bhargava HN; Reddy PL; Gudehithlu KP
    Gen Pharmacol; 1995 Jan; 26(1):131-6. PubMed ID: 7713352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levels of immunoreactive dynorphin A1-13 during development of morphine dependence in rats.
    Wan XW; Li WH; Huang M; You ZD; Tan YX; Lu CL; Gong ZH
    Zhongguo Yao Li Xue Bao; 1998 Nov; 19(6):560-3. PubMed ID: 10437147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distribution of morphine in brain regions, spinal cord and serum following intravenous injection to morphine tolerant rats.
    Bhargava HN; Villar VM; Rahmani NH; Larsen AK
    Brain Res; 1992 Nov; 595(2):228-35. PubMed ID: 1467968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diurnal variation in the acute effects of estradiol and progesterone on beta-endorphin and Met-enkephalin levels in specific brain regions of ovariectomized rats.
    Gordon FT; Soliman MR
    Pharmacology; 1994 Sep; 49(3):192-8. PubMed ID: 7972334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics of precipitated withdrawal from spinal morphine: changes in [Met5]enkephalin levels.
    Cridland RA; Sutak M; Jhamandas K
    Eur J Pharmacol; 1991 Oct; 203(1):93-103. PubMed ID: 1797559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of reserpine on catecholamine contents and met-enkephalin and beta-endorphin levels in the hypothalamus and the pituitary.
    Tang F
    Clin Exp Pharmacol Physiol; 1991 Jun; 18(6):425-9. PubMed ID: 1914245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of chronic treatment with morphine, midazolam, and both together on beta-endorphin levels in the rat.
    Rattan AK; Tejwani GA
    Brain Res Bull; 1996; 41(6):335-41. PubMed ID: 8973837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Release of immunoreactive met-enkephalin by intraventricular beta-endorphin in anesthetized rats.
    Tseng LF; King RC; Fujimoto JM
    Regul Pept; 1986 May; 14(3):181-92. PubMed ID: 2941824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of chronic morphine treatment on beta-endorphin-related peptides in the caudal medulla and spinal cord.
    Bronstein DM; Gutstein HB; Akil H
    J Neurochem; 1993 Jun; 60(6):2304-7. PubMed ID: 8492132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of mediobasal hypothalamic lesion on immunoreactive ACTH/beta-endorphin levels in cerebrospinal fluid, in discrete brain regions, in plasma, and in pituitary of the rat.
    Barna I; Koenig JI
    Brain Res; 1992 Oct; 593(1):69-76. PubMed ID: 1333872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Age-related changes in cortico-releasing factor, somatostatin, neuropeptide Y, methionine enkephalin and beta-endorphin in specific rat brain areas.
    Kowalski C; Micheau J; Corder R; Gaillard R; Conte-Devolx B
    Brain Res; 1992 Jun; 582(1):38-46. PubMed ID: 1354012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of chronic treatment with morphine, midazolam and both together on dynorphin(1-13) levels in the rat.
    Rattan AK; Tejwani GA
    Brain Res; 1997 Apr; 754(1-2):239-44. PubMed ID: 9134981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down-regulation of proopiomelanocortin synthesis and beta-endorphin utilization in hypothalamus of morphine-tolerant rats.
    Mocchetti I; Ritter A; Costa E
    J Mol Neurosci; 1989; 1(1):33-8. PubMed ID: 2534967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opioid peptides in pituitary gland, brain regions and peripheral tissues of spontaneously hypertensive and Wistar-Kyoto normotensive rats.
    Bhargava HN; Matwyshyn GA; Hanissian S; Tejwani GA
    Brain Res; 1988 Feb; 440(2):333-40. PubMed ID: 2896047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in met-enkephalin and beta-endorphin contents in the hypothalamus and the pituitary in diabetic rats: effects of insulin therapy.
    Tang F
    Clin Exp Pharmacol Physiol; 1989 Feb; 16(2):65-75. PubMed ID: 2523766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of morphine and naloxone on the levels of ACTH and beta-endorphin in plasma, brain and pituitary of rats.
    Bruni G; Dal Pra P; Fiaschi AI; Segre G
    Pharmacol Res Commun; 1985 Jul; 17(7):659-69. PubMed ID: 2996032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age-related and diurnal changes in Met5-Enk-Arg6-Phe7 and Met5-enkephalin contents of pituitary and rat brain structures.
    Tang F; Tang J; Chou J; Costa E
    Life Sci; 1984 Aug; 35(9):1005-14. PubMed ID: 6088930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Down-regulation of hypothalamic 5-HT1A receptors in morphine-abstinent rats.
    Gulati A; Bhargava HN
    Eur J Pharmacol; 1990 Jul; 182(2):253-9. PubMed ID: 2144490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endocrine control of hypothalamic and pituitary met-enkephalin and beta-endorphin contents.
    Tang F
    Neuroendocrinology; 1991; 53 Suppl 1():68-76. PubMed ID: 1901393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.